GILPIN WEALTH MANAGEMENT, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 2058144
DENVER, CO
Position in PTGX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,103
+$155 QoQ
Shares Held
9
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#327
of 341 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GILPIN WEALTH MANAGEMENT, LLC holds $898,245 across 21 Biotechnology names. PTGX ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OTLK |
Outlook Therapeutics, Inc.
|
555,000 | $882,450 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
302 | $5,109 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
28 | $1,538 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
16 | $1,391 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
3 | $1,115 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
This page
|
9 | $1,103 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
3 | $948 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
11 | $897 |
All Filings in PTGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,103 | 9 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $948 | 9 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $436 | 5 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||